Gene targeting approaches to the autonomic nervous system

Journal of the Autonomic Nervous System

Volumn 61, Issue 1, 1996, Pages 1-5

  Fritz, Jeffery D ^a   Robertson, David ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Autonomic; Homologous recombination; Hypertension; Hypotension; Knockout mice; Transgenic

Indexed keywords

GENE PRODUCT;

ANIMAL MODEL; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; GENE TARGETING; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; TRANSGENIC ANIMAL;

EID: 0030574049     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1838(96)00055-0     Document Type: Review

References (63)

1. [1] Robertson, D., Genetics and molecular biology of hypotension, Curr. Opin. Neurol., 3 (1994) 13-24.
2. [2] Dzau, V.J., Gibbons, G.H., Kobilka, B.K., Lawn, R.M. and Pratt, R.E., Genetic models of human vascular disease, Circulation, 91 (1995) 521-531.
3. [3] Smithies, O. and Maeda, N., Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension, Proc. Natl. Acad. Sci. USA, 92 (1995) 5266-5272.
4. [4] Bader, M., Zhao, Y., Sander, M., Lee, M.A., Bachmann, J., Bohm, M., Djavidani, B., Peters, J., Mullins, J.J. and Ganten, D., Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension, 19 (1992) 681-686.
5. [5] Kim, H.S., Krege, J.H., Kluckman, K.D., Hagaman, J.R., Hodgin, J.B., Best, C.F., Jennette, J.C., Coffman, T.M., Maeda, N. and Smithies, O., Genetic control of blood pressure and the angiotensinogen locus, Proc. Natl. Acad. Sci. USA, 92 (1995) 2735-2739.
6. [6] Kimura, S., Mullins, J.J., Bunnemann, B., Metzger, R., Hilgenfeldt, U., Zimmermann, F., Jacob, H., Fuxe, K., Ganten, D. and Kaling, M., High blood pressure in transgenic mice carrying the rat angiotensinogen gene, EMBO J., 11 (1992) 821-827.
7. [7] Ogawa, Y., Itoh, H., Tamura, N., Suga, S., Yoshimasa, T., Uehira, M., Matsuda, S., Shiono, S., Nishimoto, H. and Nakao, K., Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene, J. Clin. Invest., 93 (1994) 1911-1921.
8. +-proton exchanger, Circ. Res., 76 (1995) 148-153.
9. [9] Wolff, J.A., ed., Gene Therapeutics: Methods and Applications of Direct Gene Transfer, Birkhäuser, Boston. 1994.
10. [10] Smithies, O. and Kim, H-.S., Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice, Proc. Natl. Acad. Sci. USA, 91 (1994) 3612-3615.
11. [11] Krege, J.H., Hodgin, J.B., Hagaman, J.R. and Smithies, O., A noninvasive computerized tail-cuff system for measuring blood pressure in mice, Hypertension, 25 (1995) 1111-1115.
12. [12] Brandon, E.P., Idzerda, R.L. and McKnight, G.S., Targeting of the mouse genome: A compendium of knockouts. Cur. Biol., 5 (1995) 625-634, 758-765, 874-881.
13. [13] Picciotto, M.R., Zoli, M., Lena, C., Bessis, A., Lallemand, Y., LeNovere, N., Vincent, P., Pich, E.M., Brulet, P. and Changeux, J.P., Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain, Nature, 374 (1995) 65-67.
14. 1 receptor mutant mice, Cell, 79 (1995) 945-955.
15. 1A dopamine receptors, Proc. Natl. Acad. Sci. USA, 91 (1994) 12564-12568.
16. [16] Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G.F., Graybiel, A.M. and Tonegawa, S., Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses, Cell, 79 (1994) 729-742.
17. [17] Baik, J.H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., LeMeur, M. and Borrelli, E., Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377 (1995) 424-428.
18. [18] Link, R.E., Stevens, M.S., Kulatunga, M., Scheinin, M., Barsh, G.S. and Kobilka, B.K., Targeted inactivation of the gene encoding the mouse Alpha2-C-adrenoreceptor homolog, Mol. Pharmacol., 48 (1995) 48-55.
19. 1B receptor, Science, 265 (1994) 1875-1878.
20. [20] Aiba, A., Chen, C., Herrup, K., Rosenmund, C., Stevens, C.F. and Tonegawa, S., Reduce hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice, Cell, 79 (1994) 365-375.
21. [21] Aiba, A., Kano, M., Chen, C., Stanton, M.E., Fox, G.D., Herrup, K., Zwingman, T.A. and Tonegawa, S., Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice, Cell, 79 (1994) 377-388.
22. [22] Forrest, D., Yuzake, M., Soares, H.D., Ng, L., Luk, D.C., Sheng, M., Stewart, C.L., Morgan, J.I., Connor, J.A. and Curran, T., Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death, Neuron. 13 (1994) 325-338.
23. [23] Li, Y., Erzurumlu, R.S., Chen, C., Jhaveri, S. and Tonegawa, S., Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice, Cell, 76 (1994) 427-437.
24. [24] Sakimura, K., Kutsuwada, T., Ito, I., Manabe, T., Takayama, C., Kushiya, E., Yagi, T., Aizawa, S., Inoue, Y., Sugiyama, H. and Mishina, M., Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ∈1 subunit, Nature, 373 (1995) 151-155.
25. [25] Hosoda, K., Hammer, R.E., Richardson, J.A., Baynash, A.G., Cheung, J.C., Giaid, A. and Yanagisawa, M., Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice, Cell (1994) 1267-1276.
26. [26] Ito, M., Oliverio, M.I., Mannon, P.J., Best, C.F., Maeda, N., Smithies, O. and Coffman, T.M., Regulation of blood pressure by the type A1 angiotensin receptor gene, Proc. Natl. Acad. Sci. USA, 92 (1995) 3521-3525.
27. [27] Sugaya, T., Nishimatsu, S., Tanimoto, K., Takimoto, E., Yamagishi, T., Imamura. K., Goto, S., Imaizumi, K., Hisada, Y., Otsuka, A., Uchida, H., Sugiura, M., Fukuta, K., Fukamizu, A. and Murakami, K., Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia, J. Biol. Chem., 270 (1995) 18719-18722.
28. [28] Ichiki, T., Labosky, P.A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B.L.M. and Inagami, T., Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature, 377 (1995) 748-750.
29. [29] Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J. and Kobilka, B.K., Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice, Nature, 377 (1995) 744-747.
30. [30] Lopez, M.J., Wong, S.K.F., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., Garbers, D.,L and Beuve, A., Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide, Nature, 378 (1995) 65-68.
31. [31] Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. and Pachnis, V., Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret, Nature, 367 (1994) 380-383.
32. [32] Lubahn, D.B., Moyer, J.S., Golding, T.S., Couse, J.F., Korach, K.S. and Smithies, O., Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene, Proc. Natl. Acad. Sci. USA, 90 (1993) 11162-11166.
33. [33] Smeyne, R.J., Klein, R., Schnapp, A., Long, L.K., Bryant, S., Lewin, A., Lira, S.A. and Barbacid, M., Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene, Nature, 368 (1994) 246-249.
34. [34] Klein, R., Smeyne, R.J., Wurst, W., Long, L.K., Auerbach, B.A., Joyner, A.L. and Barbacid, M., Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death, Cell, 75 (1993) 113-122.
35. [35] Tanimoto, K., Sugiyama, F., Goto, Y., Ishida, J., Takimoto, E., Yagami, K., Fukamizu, A. and Murakami, K., Angiotensinogen-deficient mice with hypotension, J. Biol. Chem., 269 (1994) 31334-31337.
36. [36] Krege, J.H., John, S.W., Langenbach, L.L., Hodgin, J.B., Hagaman, J.R., Bachman, E.S., Jennette, J.C., O'Brien, D.A. and Smithies, O., Male-female differences in fertility and blood pressure in ACE-deficient mice, Nature, 375 (1995) 146-148.
37. [37] John, S.W.M., Krege, J.H., Oliver, P.M., Hagaman, J.R., Hodgin, J.B., Pang, S.C., Flynn, T.G. and Smithies, O., Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension, Science. 267 (1995) 679-681.
38. [38] Muglia, L., Jacobson, L., Dikkes, P. and Majzoub, J.A., Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need, Nature, 373 (1995) 427-432.
39. [39] Kuwaki, T., Kurihara, Y., Kurihara, H., Yazaki, Y. and Kumada, M., Role of endothelin in central cardiorespiratory control: Modern and classical approaches, News Physiol. Sci., 10 (1995) 228-233.
40. [40] Kurihara, Y., Kurihara, H., Oda, H., Maemura, K., Nagai, R., Ishikawa, T. and Yazaki, Y., Aortic arch malformations and ventricular septal detect in mice deficient in endothelin-1, J. Clin. Invest., 96 (1995) 293-300.
41. [41] Baynash, A.G., Hosoda, K., Giaid, A., Richardson, J.A., Ernoto, N., Hammer, R.E. and Yanagisawa, M., Interaction of endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell, 79 (1994) 1277-1285.
42. [42] Thomas, S.A., Matsumoto, A.M. and Palmiter, R.D., Noradrenaline is essential for mouse fetal development, Nature, 374 (1995) 643-646.
43. [43] Zhou, Q-Y., Quaife, C.J. and Palmiter, R.D., Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development, Nature, 374 (1995) 640-643.
44. [44] Huang, Z., Huang, P.L., Panahian, N., Dalkara, T., Fishman, M.C. and Moskowitz, M.A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science, 265 (1994) 1883-1885.
45. [45] O'Dell, T.J., Huang, P.L., Dawson, T.M., Dinerman, J.L., Snyder, S.H., Kandel, E.R. and Fishman, M.C., Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS, Science, 265 (1994) 542-546.
46. [46] Huang, P.L., Dawson, T.M., Bredt, D.S., Snyder, S.H. and Fishman. M.C., Targeted disruption of the neuronal nitric oxide synthase gene, Cell, 75 (1993) 1273-1286.
47. [47] Laubach, V.E., Shesely, E.G., Smithies, O. and Sherman, P.A., Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death, Proc. Natl. Acad. Sci. USA, 92 (1995) 10688-10692.
48. [48] Langenbach, R., Morham, S.G., Tiano, H.F., Loftin, C.D., Ghanayem, B.I., Chulada, P.C., Mahler, J.F., Lee, C.A., Goulding, E.H., Kluckman, K.D., Kim, H.S. and Smithies, O., Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration, Cell, 83 (1995) 483-492.
49. [49] Morham, S.G., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.C., Mahler, J.F., Kluckman, K.D., Ledford, A., Lee, C.A. and Smithies, O., Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83 (1995) 473-482.
50. [50] Wu, Z-L., Thomas, S.A., Villacres, B.C., Xia, Z., Simmons, M.L., Chavkin, C., Palmiter, R.D. and Storm, D.R., Altered behavior and long-term potentiation in type I adenylyl cylcase mutant mice, Proc. Natl. Acad. Sci. USA, 92 (1995) 220-224.
51. [51] Ingraham, H.A., Lala, D.S., Ikeda, Y., Luo, X., Shen, W.H., Nachtigan, M.W., Abbud, R., Nikon, J.H. and Parker, K.L., The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis, Genes Dev., 8 (1994) 2302-2312.
52. [52] Luo, X., Ikeda, Y. and Parker, K.L., A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation, Cell, 77 (1994) 481-490.
53. [53] Crowley, C., Spencer, S.D., Nishimura, M.C., Chen, K.S., PittsMeek, S., Armanini, M.P., Ling, L.H., McMahon, S.B., Shelton, D.L., Levinson, A.D. and Phillips, H.S., Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell, 76 (1994) 1001-1011.
54. [54] Jacks, T., Shih, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A. and Weinberg, R.A., Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet., 7 (1994) 353-361.
55. [55] Brannan, C.I., Perkins, A.S., Vogel, K.S., Ratner, N., Nordlund, M.,L, Reid, S.W., Buchberg, A.M., Jenkins, N.A., Parada, L.F. and Copeland, N.G., Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues, Genes Dev., 8 (1994) 1019-1029.
56. [56] Farinas, I., Jones, K.R., Backus, C., Wang, X-Y. and Reichardt, L.F., Severe sensory and sympathetic deficits in mice lacking neurotrophin-3, Nature, 369 (1994) 658-661.
57. [57] Tessarollo, L., Vogel, K.S., Palko, M.E., Reid, S.W. and Parada, L.F., Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons, Proc. Natl. Acad. Sci. USA, 91 (1994) 11844-11848.
58. [58] Emfors, P., Lee, K.F., Kucera, J. and Jaenisch, R., Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents, Cell, 77 (1994) 503-512.
59. [59] Guillemot, F., Lo, L-C., Johnson, J.E., Auerbach, A., Anderson, D.J. and Joyner, A.L., Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons, Cell, 75 (1993) 463-476.
60. [60] Huizinga, J.D., Thuneburg, L., Kluppel, M., Malysz, J., Mikkelsen, H.B. and Bernstein, A., W/kit gene required for interstital cells of Cajall and for intestinal pacemaker activity, Nature, 373 (1995) 347-349.
61. [61] Sauer, B., Manipulation of transgenes by site-specific recombination: Use of Cre recombinase, Methods Enzymol., 225 (1993) 890-900.
62. [62] Robertson, D., Perry, S.E., Hollister, A.S., Robertson, R.M. and Biaggioni, I., Dopamine-β-hydroxylase deficiency: A genetic disorder of cardiovascular regulation, Hypertension, 18 (1991) 1-8.
63. [63] Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G., Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transport, Nature, 379 (1996) 606.